Sexual dimorphism in cardiac remodeling: the molecular mechanisms ruled by sex hormones in the heart

[1]  Brian A. Aguado,et al.  Matters of the heart: Cellular sex differences. , 2021, Journal of molecular and cellular cardiology.

[2]  Xiumeng Hua,et al.  Single-Cell Transcriptomic Atlas of Different Human Cardiac Arteries Identifies Cell Types Associated With Vascular Physiology , 2021, Arteriosclerosis, thrombosis, and vascular biology.

[3]  R. Mostany,et al.  Alterations in the estrogen receptor profile of cardiovascular tissues during aging , 2021, GeroScience.

[4]  D. Kass,et al.  Cellular and molecular pathobiology of heart failure with preserved ejection fraction , 2021, Nature Reviews Cardiology.

[5]  Catherine L. Worth,et al.  Cells of the adult human heart , 2020, Nature.

[6]  C. Shim.  Heart Failure with Preserved Ejection Fraction: the Major Unmet Need in Cardiology , 2020, Korean circulation journal.

[7]  M. Eghbali,et al.  The Role of Estrogen Receptors in Cardiovascular Disease , 2020, International journal of molecular sciences.

[8]  M. Estrada,et al.  Androgen-Regulated Cardiac Metabolism in Aging Men , 2020, Frontiers in Endocrinology.

[9]  V. Regitz-Zagrosek.  Sex and Gender Differences in Heart Failure , 2020, International journal of heart failure.

[10]  S. Anker,et al.  Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future , 2020, Clinical Research in Cardiology.

[11]  Wenwei Bai,et al.  Testosterone Supplementation in Patients With Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials , 2020, Frontiers in Endocrinology.

[12]  F. Brozovich,et al.  The vasculature in HFpEF vs HFrEF: differences in contractile protein expression produce distinct phenotypes , 2019, Heliyon.

[13]  D. Kitzman,et al.  Heart failure with preserved ejection fraction: New approaches to diagnosis and management , 2019, Clinical cardiology.

[14]  Sanjiv J. Shah,et al.  Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction , 2019, Circulation.

[15]  H. D. den Ruijter,et al.  Estrogen Contributions to Microvascular Dysfunction Evolving to Heart Failure With Preserved Ejection Fraction , 2019, Front. Endocrinol..

[16]  Yangxin Li,et al.  The Influence of Sex on Cardiac Physiology and Cardiovascular Diseases , 2019, Journal of Cardiovascular Translational Research.

[17]  E. Dworatzek,et al.  The Role of 17β-Estradiol and Estrogen Receptors in Regulation of Ca2+ Channels and Mitochondrial Function in Cardiomyocytes , 2019, Front. Endocrinol..

[18]  R. Wachter,et al.  Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction , 2019, Journal of clinical medicine.

[19]  A. Abreu,et al.  Exercise training in women with cardiovascular disease: Differential response and barriers - review and perspective. , 2019, European journal of preventive cardiology.

[20]  J. Lindenfeld,et al.  Sex Differences in Outcomes and Responses to Spironolactone in Heart Failure With Preserved Ejection Fraction: A Secondary Analysis of TOPCAT Trial. , 2019, JACC. Heart failure.

[21]  V. Regitz-Zagrosek,et al.  Sex-specific regulation of cardiac microRNAs targeting mitochondrial proteins in pressure overload , 2019, Biology of Sex Differences.

[22]  R. Mostany,et al.  Estrogen receptor profiles across tissues from male and female Rattus norvegicus , 2019, Biology of Sex Differences.

[23]  G. Su,et al.  G Protein-Coupled Estrogen Receptor 1 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy via the Regulation of PI3K-Akt-mTOR Signalling and Autophagy , 2019, International journal of biological sciences.

[24]  N. Stachenfeld,et al.  Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. , 2018, American journal of physiology. Heart and circulatory physiology.

[25]  Mohammad T Elnakish,et al.  Protein Kinase A as a Promising Target for Heart Failure Drug Development. , 2018, Archives of medical research.

[26]  Shiqiang Yu,et al.  GPR30 Attenuates Myocardial Fibrosis in Diabetic Ovariectomized Female Rats: Role of iNOS Signaling. , 2018, DNA and cell biology.

[27]  V. Regitz-Zagrosek,et al.  Sex-specific regulation of collagen I and III expression by 17&bgr;-Estradiol in cardiac fibroblasts: role of estrogen receptors , 2018, Cardiovascular research.

[28]  T. Marwick,et al.  Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction , 2018, Circulation.

[29]  J. Tardif,et al.  Sex, drugs, and heart failure: a sex‐sensitive review of the evidence base behind current heart failure clinical guidelines , 2018, ESC heart failure.

[30]  H. Van Remmen,et al.  G protein‐coupled estrogen receptor (GPER) deficiency induces cardiac remodeling through oxidative stress , 2018, Translational research : the journal of laboratory and clinical medicine.

[31]  L. Lei,et al.  Hormone treatments in congestive heart failure , 2018, The Journal of international medical research.

[32]  M. Eghbali,et al.  The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy , 2017, Biology of Sex Differences.

[33]  I. Lambrinoudaki,et al.  Androgens and cardiovascular disease in women and men. , 2017, Maturitas.

[34]  K. Yin,et al.  Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease. , 2017, American journal of physiology. Heart and circulatory physiology.

[35]  E. Claudio,et al.  GPER modulates tone and coronary vascular reactivity in male and female rats. , 2017, Journal of molecular endocrinology.

[36]  A. Goette,et al.  Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men , 2017, Experimental biology and medicine.

[37]  I. König,et al.  Sex in basic research: concepts in the cardiovascular field. , 2017, Cardiovascular research.

[38]  Shannon M. Dunlay,et al.  Epidemiology of heart failure with preserved ejection fraction , 2017, Nature Reviews Cardiology.

[39]  E. Dworatzek,et al.  Targeted basic research to highlight the role of estrogen and estrogen receptors in the cardiovascular system , 2017, Pharmacological research.

[40]  E. Morselli,et al.  The effects of oestrogens and their receptors on cardiometabolic health , 2017, Nature Reviews Endocrinology.

[41]  M. Budoff,et al.  Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone , 2017, JAMA.

[42]  G. Norton,et al.  Sex-Specific Effects of Adrenergic-Induced Left Ventricular Remodeling in Spontaneously Hypertensive Rats. , 2017, Journal of cardiac failure.

[43]  I. Barba,et al.  High-fat diet induces metabolic changes and reduces oxidative stress in female mouse hearts. , 2017, The Journal of nutritional biochemistry.

[44]  M. Estrada,et al.  GSK-3β/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy , 2016, PloS one.

[45]  E. Levin,et al.  Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors , 2016, Nature Reviews Molecular Cell Biology.

[46]  G. Hankins,et al.  Testosterone downregulates angiotensin II type-2 receptor via androgen receptor-mediated ERK1/2 MAP kinase pathway in rat aorta , 2016, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[47]  J. Jose,et al.  Testosterone as a marker of coronary artery disease severity in middle aged males , 2016, Indian heart journal.

[48]  J. K. Kim,et al.  The Role of Estrogen and Estrogen Receptors on Cardiomyocytes: An Overview. , 2016, The Canadian journal of cardiology.

[49]  M. L. Porto,et al.  Sex differences in the regulation of spatially distinct cardiac mitochondrial subpopulations , 2016, Molecular and Cellular Biochemistry.

[50]  Wendy J Mack,et al.  Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. , 2016, The New England journal of medicine.

[51]  E. Murphy,et al.  The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System. , 2016, Circulation research.

[52]  Susan Cheng,et al.  Sex differences in cardiovascular ageing , 2016, Heart.

[53]  M. Bauzá-Thorbrügge,et al.  GPER mediates the effects of 17β-estradiol in cardiac mitochondrial biogenesis and function , 2016, Molecular and Cellular Endocrinology.

[54]  E. Dworatzek,et al.  Effects of aging on cardiac extracellular matrix in men and women , 2016, Proteomics. Clinical applications.

[55]  J. Oliver,et al.  Sexual Dimorphism in the Alterations of Cardiac Muscle Mitochondrial Bioenergetics Associated to the Ageing Process. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[56]  S. Orrù,et al.  Molecular effects of supraphysiological doses of doping agents on health. , 2015, Molecular bioSystems.

[57]  L. Fu,et al.  Testosterone replacement attenuates mitochondrial damage in a rat model of myocardial infarction. , 2015, The Journal of endocrinology.

[58]  S. Howlett,et al.  Testosterone modulates cardiac contraction and calcium homeostasis: cellular and molecular mechanisms , 2015, Biology of Sex Differences.

[59]  Hao Wang,et al.  Activation of GPR30 inhibits cardiac fibroblast proliferation , 2015, Molecular and Cellular Biochemistry.

[60]  Wei Zhao,et al.  MiR-22/Sp-1 Links Estrogens With the Up-Regulation of Cystathionine γ-Lyase in Myocardium, Which Contributes to Estrogenic Cardioprotection Against Oxidative Stress. , 2015, Endocrinology.

[61]  Tepmanas Bupha-Intr,et al.  Significant role of estrogen in maintaining cardiac mitochondrial functions , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[62]  A. Godoy,et al.  Androgen receptor in human endothelial cells. , 2015, The Journal of endocrinology.

[63]  Zhuoli Zhang,et al.  17β-estradiol prevents cardiac diastolic dysfunction by stimulating mitochondrial function: A preclinical study in a mouse model of a human hypertrophic cardiomyopathy mutation , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[64]  J. Fuscoe,et al.  Sexual Dimorphism in the Expression of Mitochondria-Related Genes in Rat Heart at Different Ages , 2015, PloS one.

[65]  Yang Ruan,et al.  SIRT1 Functions as an Important Regulator of Estrogen-Mediated Cardiomyocyte Protection in Angiotensin II-Induced Heart Hypertrophy , 2014, Oxidative medicine and cellular longevity.

[66]  V. Regitz-Zagrosek,et al.  Sex‐dependent regulation of fibrosis and inflammation in human left ventricular remodelling under pressure overload , 2014, European journal of heart failure.

[67]  V. Regitz-Zagrosek,et al.  Maladaptive remodeling is associated with impaired survival in women but not in men after aortic valve replacement. , 2014, JACC. Cardiovascular imaging.

[68]  R. Rose,et al.  Sex differences in SR Ca(2+) release in murine ventricular myocytes are regulated by the cAMP/PKA pathway. , 2014, Journal of molecular and cellular cardiology.

[69]  Yi‐Jen Chen,et al.  Androgen attenuates cardiac fibroblasts activations through modulations of transforming growth factor-β and angiotensin II signaling. , 2014, International journal of cardiology.

[70]  D. Vassallo,et al.  Na+K+-ATPase Activity and K+ Channels Differently Contribute to Vascular Relaxation in Male and Female Rats , 2014, PloS one.

[71]  J. Manson,et al.  Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. , 2014, Annals of internal medicine.

[72]  B. Yao,et al.  Effects of dihydrotestosterone on adhesion and proliferation via PI3-K/Akt signaling in endothelial progenitor cells , 2014, Endocrine.

[73]  M. Guescini,et al.  Effects of sex hormones on inflammatory response in male and female vascular endothelial cells , 2014, Journal of Endocrinological Investigation.

[74]  Dong I. Lee,et al.  PDE5 inhibitor efficacy is estrogen dependent in female heart disease. , 2014, The Journal of clinical investigation.

[75]  A. Arnold,et al.  The number of X chromosomes influences protection from cardiac ischaemia/reperfusion injury in mice: one X is better than two. , 2014, Cardiovascular research.

[76]  C. Pestana,et al.  Testosterone induces apoptosis in vascular smooth muscle cells via extrinsic apoptotic pathway with mitochondria-generated reactive oxygen species involvement. , 2014, American journal of physiology. Heart and circulatory physiology.

[77]  I. Stefanon,et al.  Sex hormones in the cardiovascular system , 2014, Hormone molecular biology and clinical investigation.

[78]  T. Hsieh,et al.  The Effect of Testosterone on Cardiovascular Disease , 2014, American journal of men's health.

[79]  T. McKinsey,et al.  Estrogen regulates histone deacetylases to prevent cardiac hypertrophy , 2013, Molecular biology of the cell.

[80]  M. Estrada,et al.  Testosterone increases GLUT4‐dependent glucose uptake in cardiomyocytes , 2013, Journal of cellular physiology.

[81]  V. Regitz-Zagrosek,et al.  Sex- and estrogen-dependent regulation of a miRNA network in the healthy and hypertrophied heart. , 2013, International journal of cardiology.

[82]  R. Karas,et al.  Rapid Estrogen Receptor Signaling Mediates Estrogen-Induced Inhibition of Vascular Smooth Muscle Cell Proliferation , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[83]  W. Paulus,et al.  A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. , 2013, Journal of the American College of Cardiology.

[84]  R. Karas,et al.  Emerging evidence of the importance of rapid, non-nuclear estrogen receptor signaling in the cardiovascular system , 2013, Steroids.

[85]  T. Jones,et al.  Testosterone: a vascular hormone in health and disease. , 2013, The Journal of endocrinology.

[86]  P. Maki,et al.  Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies , 2013, Menopause.

[87]  S. Howlett,et al.  Sex differences in mechanisms of cardiac excitation–contraction coupling , 2013, Pflügers Archiv - European Journal of Physiology.

[88]  V. Regitz-Zagrosek,et al.  17β-Estradiol-induced interaction of ERα with NPPA regulates gene expression in cardiomyocytes. , 2012, Cardiovascular research.

[89]  L. Køber,et al.  Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial , 2012, BMJ : British Medical Journal.

[90]  Masahiro Akishita,et al.  Src kinase-mediates androgen receptor-dependent non-genomic activation of signaling cascade leading to endothelial nitric oxide synthase. , 2012, Biochemical and biophysical research communications.

[91]  D. Vassallo,et al.  Myocardial Contractile Dysfunction Induced by Ovariectomy Requires AT1Receptor Activation in Female Rats , 2012, Cellular Physiology and Biochemistry.

[92]  M. Ares,et al.  Androgens Contribute to Sex Differences in Myocardial Remodeling under Pressure Overload by a Mechanism Involving TGF-β , 2012, PloS one.

[93]  P. Chambon,et al.  The role of estrogen receptor α and β in regulating vascular smooth muscle cell proliferation is based on sex. , 2012, The Journal of surgical research.

[94]  V. Regitz-Zagrosek,et al.  Transcriptome characterization of estrogen-treated human myocardium identifies myosin regulatory light chain interacting protein as a sex-specific element influencing contractile function. , 2012, Journal of the American College of Cardiology.

[95]  P. Komesaroff,et al.  Physiological effects of androgens on human vascular endothelial and smooth muscle cells in culture , 2011, Steroids.

[96]  Saizhu Wu,et al.  Testosterone suppresses oxidative stress via androgen receptor-independent pathway in murine cardiomyocytes. , 2011, Molecular medicine reports.

[97]  E. Simpson,et al.  Aromatase deficiency confers paradoxical postischemic cardioprotection. , 2011, Endocrinology.

[98]  Hyung-Seok Kim,et al.  Casein Kinase-2&agr;1 Induces Hypertrophic Response by Phosphorylation of Histone Deacetylase 2 S394 and its Activation in the Heart , 2011, Circulation.

[99]  G. Nickenig,et al.  Antiproliferative effect of estrogen in vascular smooth muscle cells is mediated by Kruppel-like factor-4 and manganese superoxide dismutase , 2011, Basic Research in Cardiology.

[100]  D. Lubahn,et al.  Estrogen receptor-beta prevents cardiac fibrosis. , 2010, Molecular endocrinology.

[101]  P. Morris,et al.  Low serum testosterone and increased mortality in men with coronary heart disease , 2010, Heart.

[102]  A. Jiang,et al.  PGC-1 Coactivators in Cardiac Development and Disease , 2010, Circulation research.

[103]  M. Flamini,et al.  Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo. , 2010, Molecular human reproduction.

[104]  RolandHetzer,et al.  Regression of Myocardial Hypertrophy After Aortic Valve Replacement , 2010 .

[105]  N. Kato,et al.  VEGF signaling is disrupted in the hearts of mice lacking estrogen receptor alpha. , 2010, European journal of pharmacology.

[106]  H. Randeva,et al.  G-protein coupled estrogen receptor 1 expression in rat and human heart: Protective role during ischaemic stress. , 2010, International journal of molecular medicine.

[107]  T. Haystead,et al.  Smoothelin-like 1 Protein Regulates Myosin Phosphatase-targeting Subunit 1 Expression during Sexual Development and Pregnancy* , 2010, The Journal of Biological Chemistry.

[108]  A. Jette,et al.  Adverse events associated with testosterone administration. , 2010, The New England journal of medicine.

[109]  S. Howlett,et al.  Sex differences in mechanisms of cardiac excitation–contraction coupling , 2010, Pflügers Archiv - European Journal of Physiology.

[110]  E. Murphy,et al.  Sex Differences in the Phosphorylation of Mitochondrial Proteins Result in Reduced Production of Reactive Oxygen Species and Cardioprotection in Females , 2010, Circulation Research.

[111]  V. Regitz-Zagrosek,et al.  Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[112]  Y. Ouchi,et al.  Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: role of phosphatidylinositol 3-kinase/akt pathway. , 2010, Endocrinology.

[113]  C. Hermenegildo,et al.  Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-{alpha}. , 2010, Journal of molecular endocrinology.

[114]  A. Rousseau,et al.  Impact of age and gender interaction on circulating endothelial progenitor cells in healthy subjects. , 2010, Fertility and sterility.

[115]  M. Maggiolini,et al.  A new membrane G protein-coupled receptor (GPR30) is involved in the cardiac effects of 17beta-estradiol in the male rat. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[116]  M. Marino,et al.  Cell sex determines anoikis resistance in vascular smooth muscle cells , 2009, FEBS letters.

[117]  E. Murphy,et al.  Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. , 2009, American journal of physiology. Heart and circulatory physiology.

[118]  Seungho Wang,et al.  The interaction of estrogen receptor alpha and caveolin-3 regulates connexin43 phosphorylation in metabolic inhibition-treated rat cardiomyocytes. , 2009, The international journal of biochemistry & cell biology.

[119]  I. Netuka,et al.  Gender Differences in Cardiac Ischemic Injury and Protection—Experimental Aspects , 2009, Experimental biology and medicine.

[120]  E. Stefani,et al.  Estrogen Contributes to Gender Differences in Mouse Ventricular Repolarization , 2009, Circulation research.

[121]  M. Estrada,et al.  Testosterone induces cardiomyocyte hypertrophy through mammalian target of rapamycin complex 1 pathway. , 2009, The Journal of endocrinology.

[122]  L. Neyses,et al.  Estrogen receptor alpha interacts with 17beta-hydroxysteroid dehydrogenase type 10 in mitochondria. , 2009, Biochemical and biophysical research communications.

[123]  J. Hare,et al.  Sex‐Specific Impact of Aldosterone Receptor Antagonism on Ventricular Remodeling and Gene Expression after Myocardial Infarction , 2009, Clinical and translational science.

[124]  M. Morishima,et al.  17 beta-estradiol modulates expression of low-voltage-activated Ca(V)3.2 T-type calcium channel via extracellularly regulated kinase pathway in cardiomyocytes. , 2009, Endocrinology.

[125]  S. Grandy,et al.  Expression, Distribution and Regulation of Sex Steroid Hormone Receptors in Mouse Heart , 2009, Cellular Physiology and Biochemistry.

[126]  A. Garnier,et al.  Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. , 2008, Cardiovascular research.

[127]  M. Vannan,et al.  Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin. , 2008, Endocrinology.

[128]  A. Ahluwalia,et al.  Sex differences in vascular function: implication of endothelium-derived hyperpolarizing factor. , 2008, The Journal of endocrinology.

[129]  John J. Evans,et al.  Regulation of endothelin-1 release from human endothelial cells by sex steroids and angiotensin-II , 2008, Peptides.

[130]  S. Mumby,et al.  Direct interactions with G α i and G βγ mediate nongenomic signaling by estrogen receptor α . , 2007, Molecular endocrinology.

[131]  P. Roca,et al.  Caloric restriction and gender modulate cardiac muscle mitochondrial H2O2 production and oxidative damage. , 2007, Cardiovascular research.

[132]  G. Kirilov,et al.  Testosterone replacement therapy in male hypogonadism is not associated with increase of endothelin-1 levels. , 2007, International journal of andrology.

[133]  C. Foresta,et al.  Reduced number of circulating endothelial progenitor cells in hypogonadal men. , 2006, The Journal of clinical endocrinology and metabolism.

[134]  E. Stefani,et al.  Heart estrogen receptor alpha: distinct membrane and nuclear distribution patterns and regulation by estrogen. , 2006, Journal of molecular and cellular cardiology.

[135]  C. Teloken,et al.  Diabetes mellitus is associated with subnormal serum levels of free testosterone in men , 2005, BJU international.

[136]  Takahiro Matsumoto,et al.  Androgen Receptor Gene Knockout Male Mice Exhibit Impaired Cardiac Growth and Exacerbation of Angiotensin II-induced Cardiac Fibrosis* , 2005, Journal of Biological Chemistry.

[137]  S. Ito,et al.  Marked attenuation of production of collagen type I from cardiac fibroblasts by dehydroepiandrosterone. , 2005, American journal of physiology. Endocrinology and metabolism.

[138]  S. Chu,et al.  Sex differences in expression of calcium-handling proteins and beta-adrenergic receptors in rat heart ventricle. , 2005, Life sciences.

[139]  S. Moncada,et al.  Investigation of Vascular Responses in Endothelial Nitric Oxide Synthase/Cyclooxygenase-1 Double-Knockout Mice: Key Role for Endothelium-Derived Hyperpolarizing Factor in the Regulation of Blood Pressure in Vivo , 2005, Circulation.

[140]  James A. Clark,et al.  Estrogen receptor-β mediates male-female differences in the development of pressure overload hypertrophy , 2005 .

[141]  V. Regitz-Zagrosek,et al.  Upregulation of Myocardial Estrogen Receptors in Human Aortic Stenosis , 2004, Circulation.

[142]  R. Karas,et al.  17&bgr;-Estradiol Reduces Cardiomyocyte Apoptosis In Vivo and In Vitro via Activation of Phospho-Inositide-3 Kinase/Akt Signaling , 2004, Circulation research.

[143]  S. Schaefer,et al.  Gender modulation of Ca(2+) uptake in cardiac mitochondria. , 2004, Journal of molecular and cellular cardiology.

[144]  Y. Jiang,et al.  Testosterone Regulates mRNA Levels of Calcium Regulatory Proteins in Cardiac Myocytes , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[145]  David Handelsman,et al.  Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway. , 2004, Endocrinology.

[146]  Anne-Marie Brun-Zinkernagel,et al.  Mitochondrial localization of estrogen receptor β , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[147]  R. Khalil,et al.  Gender, sex hormones, and vascular tone. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[148]  J. Isner,et al.  Estrogen-Mediated, Endothelial Nitric Oxide Synthase–Dependent Mobilization of Bone Marrow–Derived Endothelial Progenitor Cells Contributes to Reendothelialization After Arterial Injury , 2003, Circulation.

[149]  Dan Yang,et al.  Mechanisms of 17beta-estradiol on the production of ET-1 in ovariectomized rats. , 2003, Life sciences.

[150]  T. Simoncini,et al.  Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. , 2003, Endocrinology.

[151]  Lei Li,et al.  Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[152]  Roberto Colombo,et al.  Protein carbonyl groups as biomarkers of oxidative stress. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[153]  R. Baron,et al.  Src Kinase Mediates Phosphatidylinositol 3-Kinase/Akt-dependent Rapid Endothelial Nitric-oxide Synthase Activation by Estrogen* , 2003, The Journal of Biological Chemistry.

[154]  T. Kigoshi,et al.  Testosterone inhibits tumor necrosis factor‐α‐induced vascular cell adhesion molecule‐1 expression in human aortic endothelial cells , 2002, FEBS letters.

[155]  C. Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[156]  T. Mukherjee,et al.  Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: Implications in atherosclerosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[157]  L. Dakovska,et al.  Increased plasma endothelin levels in patients with male hypogonadism , 2002, Andrologia.

[158]  A. Tedgui,et al.  Age and gender effects on cardiomyocyte apoptosis in the normal human heart. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[159]  Mark A Sussman,et al.  Myocardial Akt Activation and Gender: Increased Nuclear Activity in Females Versus Males , 2001, Circulation research.

[160]  C. Curl,et al.  Effects of gender on intracellular [Ca2+] in rat cardiac myocytes , 2001, Pflügers Archiv.

[161]  A. Özer,et al.  17β-Estradiol modulates endothelin-1 expression and release in human endothelial cells , 2000 .

[162]  J. Bender,et al.  Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[163]  E. Vittinghoff,et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.

[164]  C. Grohé,et al.  Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. , 1998, The Journal of endocrinology.

[165]  R. Karas,et al.  Cardiac myocytes and fibroblasts contain functional estrogen receptors 1 , 1997, FEBS letters.

[166]  W. Catterall,et al.  Increased Expression of the Cardiac L-type Calcium Channel in Estrogen Receptor–deficient Mice , 1997, The Journal of general physiology.

[167]  T. Kumai,et al.  Effects of ovariectomy and estrogen replacement on aorta angiotensin-converting enzyme activity in rats. , 1997, Japanese journal of pharmacology.

[168]  P. Anversa,et al.  Gender differences and aging: effects on the human heart. , 1995, Journal of the American College of Cardiology.

[169]  M. Eghbali,et al.  Gender-specific differences in expression of mRNAs for functional and structural proteins in rat ventricular myocardium. , 1994, Journal of molecular and cellular cardiology.

[170]  E. Simpson,et al.  Relative expression of aromatase cytochrome P450 in human fetal tissues as determined by competitive polymerase chain reaction amplification. , 1992, The Journal of clinical endocrinology and metabolism.

[171]  L. Heywood.  Testosterone levels in the male laboratory rat: variation under experimental conditions. , 1980, International journal of andrology.

[172]  A. Beale,et al.  Sex Differences in Heart Failure with Preserved Ejection Fraction Therapy: Potential Mechanisms and Clinical Implications , 2020 .

[173]  E. Jones.  Disease , 2020, Palgrave Studies in Economic History.

[174]  G. Heyndrickx,et al.  Heart Function Analysis in Cardiac Patients with Focus on Sex-Specific Aspects. , 2018, Advances in experimental medicine and biology.

[175]  C. Lavie,et al.  Testosterone and Cardiovascular Health , 2018, Mayo Clinic proceedings.

[176]  Georgios Kararigas,et al.  Mechanistic Pathways of Sex Differences in Cardiovascular Disease. , 2017, Physiological reviews.

[177]  B. Wan,et al.  Dihydrotestosterone modulates endothelial progenitor cell function via RhoA/ROCK pathway. , 2016, American journal of translational research.

[178]  J. Houštěk,et al.  Sex difference in the sensitivity of cardiac mitochondrial permeability transition pore to calcium load , 2015, Molecular and Cellular Biochemistry.

[179]  Richard E. White,et al.  Testosterone-induced relaxation of coronary arteries: activation of BKCa channels via the cGMP-dependent protein kinase. , 2012, American journal of physiology. Heart and circulatory physiology.

[180]  E. Barrett-Connor,et al.  Low serum testosterone and mortality in older men. , 2008, The Journal of clinical endocrinology and metabolism.

[181]  Greta L. Hoetzer,et al.  Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults. , 2007, The American journal of cardiology.

[182]  P. Doevendans,et al.  Estrogen receptor beta protects the murine heart against left ventricular hypertrophy. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[183]  E. Levin,et al.  Estrogen Inhibits Cardiomyocyte Hypertrophy in Vitro : ANTAGONISM OF CALCINEURIN-RELATED HYPERTROPHY THROUGH INDUCTION OF MCIP1* , 2005 .

[184]  K. Korach,et al.  Estrogen receptor- (cid:1) mediates male-female differences in the development of pressure overload hypertrophy , 2004 .

[185]  Anne-Marie Brun-Zinkernagel,et al.  Mitochondrial localization of estrogen receptor beta. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[186]  E. Levin,et al.  ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. , 2002, Molecular endocrinology.

[187]  Hong Zhao,et al.  Effects of testosterone and 17-beta-estradiol on TNF-alpha-induced E-selectin and VCAM-1 expression in endothelial cells. Analysis of the underlying receptor pathways. , 2002, Life sciences.

[188]  M. Ziolo,et al.  Mechanisms of sex differences in rat cardiac myocyte response to beta-adrenergic stimulation. , 2002, American journal of physiology. Heart and circulatory physiology.

[189]  M. Chappell,et al.  Estrogen regulation of angiotensin-converting enzyme mRNA. , 1999, Hypertension.

[190]  V. Regitz-Zagrosek,et al.  The FASEB Journal • Research Communication Estrogen receptor alpha up-regulation and redistribution in human heart failure , 2022 .

[191]  V. Vladimir,et al.  Spotlight Issue on Signaling in Cardiac Metabolism: Transcriptional Control of Mitochondrial Biogenesis. the Central Role of Pgc-1α , 2022 .